PIIIW Current Deferred Revenue from 2010 to 2025

PIIIW Stock  USD 0.01  0  7.14%   
P3 Health Current Deferred Revenue yearly trend continues to be fairly stable with very little volatility. Current Deferred Revenue is likely to outpace its year average in 2025. Current Deferred Revenue is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. View All Fundamentals
 
Current Deferred Revenue  
First Reported
2010-12-31
Previous Quarter
-2.4 M
Current Value
-2.3 M
Quarterly Volatility
15.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 104.7 M, Interest Expense of 17.5 M or Selling General Administrative of 133.7 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.96. PIIIW financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
  
Check out the analysis of P3 Health Correlation against competitors.

Latest P3 Health's Current Deferred Revenue Growth Pattern

Below is the plot of the Current Deferred Revenue of P3 Health Partners over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. P3 Health's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
Current Deferred Revenue10 Years Trend
Slightly volatile
   Current Deferred Revenue   
       Timeline  

PIIIW Current Deferred Revenue Regression Statistics

Arithmetic Mean17,182,456
Geometric Mean10,552,774
Coefficient Of Variation89.51
Mean Deviation14,416,654
Median28,715,779
Standard Deviation15,380,453
Sample Variance236.6T
Range31.4M
R-Value(0.84)
Mean Square Error73.2T
R-Squared0.71
Significance0.000041
Slope(2,724,212)
Total Sum of Squares3548.4T

PIIIW Current Deferred Revenue History

2025-2.3 M
2024-2.4 M
2023-2.7 M
2020-1.6 M

About P3 Health Financial Statements

P3 Health investors use historical fundamental indicators, such as P3 Health's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in P3 Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-2.4 M-2.3 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.